−0.0140USD
−10.41 MUSD
1.96 MUSD
386.67 M
About Starpharma Holdings Ltd.
Sector
CEO
Cheryl Maley
Headquarters
Abbotsford
Website
Employees (FY)
45
Founded
1997
ISIN
AU000000SPL0
FIGI
BBG000CST0L9
Starpharma Holdings Ltd. engages in the research and development of dendrimer products for pharmaceutical, life science and other applications. The firm's programs include: VivaGel portfolio, Drug delivery and Agrochemicals, which develops a number of products internally and others via commercial partnerships. Its product VivaGel, a gel-based formulation of a proprietary dendrimer and is under clinical development for the treatment and prevention of bacterial vaginosis and also as a vaginal microbicide to prevent the transmission of sexually transmitted infections including HIV and genital herpes. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SPHRF is 0.0991 USD — it has decreased by 4.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Starpharma Holdings Ltd. stocks are traded under the ticker SPHRF.
Starpharma Holdings Ltd. is going to release the next earnings report on Aug 21, 2024. Keep track of upcoming events with our Earnings Calendar.
SPHRF stock is 17.04% volatile and has beta coefficient of 0.50. Check out the list of the most volatile stocks — is Starpharma Holdings Ltd. there?
Starpharma Holdings Ltd. revenue for the last quarter amounts to 2.14 M USD despite the estimated figure of 2.14 M USD. In the next quarter revenue is expected to reach 6.13 M USD.
Yes, you can track Starpharma Holdings Ltd. financials in yearly and quarterly reports right on TradingView.
SPHRF net income for the last quarter is −703.93 K USD, while the quarter before that showed −4.90 M USD of net income which accounts for 85.64% change. Track more Starpharma Holdings Ltd. financial stats to get the full picture.
Today Starpharma Holdings Ltd. has the market capitalization of 36.14 M, it has increased by 13.10% over the last week.
No, SPHRF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SPHRF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Starpharma Holdings Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 45.00 employees. See our rating of the largest employees — is Starpharma Holdings Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Starpharma Holdings Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Starpharma Holdings Ltd. stock shows the sell signal. See more of Starpharma Holdings Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Starpharma Holdings Ltd. EBITDA is −10.39 M USD, and current EBITDA margin is −798.91%. See more stats in Starpharma Holdings Ltd. financial statements.